Showing 30 of 3541 posts
Portmeirion Group's 2025 results: loss from US tariffs, but strategic transformation and stronger Q1 2026 trading offer cautious optimism.
JoshuaMay 6, 2026
RWS Holdings agrees to acquire Obviously Group for up to £40m, boosting AI-powered IP & brand protection. Deal not yet finalised.
JoshuaMay 5, 2026
Fusion Antibodies reports 9% revenue growth, margins up to 50%, cash doubles to £1m+, and strategic wins with larger pharma clients. Cautiously optimistic FY2027 outlook.
JoshuaMay 5, 2026
Autins Group returns to net profit with major contract wins and margin expansion, despite lower revenue. Encouraging FY27-28 outlook.
JoshuaMay 5, 2026
Kosmos Energy's record Q1 production drives positive free cash flow and a 20% debt reduction target after bond deal, equity raise, and asset sale.
JoshuaMay 5, 2026
AEP Plantations buys PT Pinago Utama Tbk for $162M in cash, boosting CPO output by 25% with immediate earnings accretion.
JoshuaMay 5, 2026
Camellia swings to £1.0m trading profit in FY25, with VEP progress and balance sheet strength, but statutory losses remain.
JoshuaMay 5, 2026
Vodafone buys full control of VodafoneThree for £4.3bn, gaining 100% of UK’s largest mobile network with £700m synergy target.
JoshuaMay 5, 2026
Invinity accelerates cost reduction (66% target) and unveils £14m-£234m revenue outlook for 2026-2028, but Hungary delays temper short-term optimism.
JoshuaMay 5, 2026
Crimson Tide returns to profitability in FY26 with improved cash generation, but high churn remains a key risk for future growth. Read the full analysis.
JoshuaMay 5, 2026
Air Astana Q1 2026: revenue up 13% but profits plunged as costs surged. Engine problems and Gulf conflict hurt margins. March recovery gives hope.
JoshuaMay 5, 2026
MHP SE 2025 results: revenue up 24%, net profit rises to $187m, UVESA acquisition boosts European presence. But margins slip to 10%, debt higher. Full analysis.
JoshuaMay 5, 2026
Hemogenyx Pharmaceuticals 2025 final results: Phase 1 HG-CT-1 trial progresses with DSMB clearance, but losses and dilution continue. Full analysis.
JoshuaMay 1, 2026
First Class Metals annual results: Sunbeam promising, but cash just £77k highlights funding risk. Asset monetisation key. Better rocks, tight balance sheet.
JoshuaMay 1, 2026
Africa Opportunity Fund's 2025 NAV jumps 26% to $1.51/share, but market cap stagnates-a deep discount persists as the fund pivots from liquidation to growth.
JoshuaMay 1, 2026
Santander UK completes £2.65bn TSB acquisition, boosting market position with £400m cost synergy target and 16% RoTE goal by 2028.
JoshuaMay 1, 2026
Pearson Q1 2026: 4% underlying sales growth with Virtual Learning surging 21%. Full-year guidance unchanged after a solid start.
JoshuaMay 1, 2026
NewRiver REIT delivers strong FY results with Capital & Regional integration complete, £6.2m synergies, resilient leasing and a strengthened balance sheet.
JoshuaMay 1, 2026
ProService: FY26 revenue miss, EBITDA breakeven. Refinancing overhang & FY27 guidance slashed. Speedy Hire deal shows promise but slow ramp-up. Full insight.
JoshuaMay 1, 2026
Aterian’s 2025 results: trading revenue rises, exploration advances, but widening losses and tight cash leave going concern a key risk.
JoshuaMay 1, 2026
NatWest Markets Q1 2026 profit halved to £28m amid market volatility, but strong capital and litigation progress offer stability.
JoshuaMay 1, 2026
NatWest raises 2026 income guidance after strong Q1 with solid lending growth, cost control, and robust capital. Impairments rose but outlook remains positive.
JoshuaMay 1, 2026
Scott Oriental Trust's NAV fell 2.3% as benchmark surged; conditional tender offer looms if five-year performance fails.
JoshuaMay 1, 2026
ACCRUFeR sales surge 54% as Shield hits positive EBIT, but $7.9M milestone flatters numbers. CFO exits, NY Medicaid risk awaits.
JoshuaMay 1, 2026
Team PLC completes EPIC Guernsey acquisition, paying with 5.2m new shares. Strategic fit for wealth management but dilution hits 4.6%.
JoshuaMay 1, 2026
MJ Gleeson reports resilient trading but warns on legacy costs and Middle East uncertainty, with adjusted profit guidance conditional on major land sale.
JoshuaMay 1, 2026
Pulsar Group's FY25 results show strong ARR growth to £64.5m and improved profitability, though statutory losses widened. Cost cutting and AI product push mark a transition.
JoshuaMay 1, 2026
Mkango files Songwe Hill DFS, reports US$3.1m cash, raises £11.7m, and advances HyProMag recycling with first customer shipments.
JoshuaMay 1, 2026
RMII wind-down returns 50% capital, but NAV falls 10% as riskier assets remain. Key insights on Beinbauer, Energie, Trianco.
JoshuaMay 1, 2026
Unilever Q1 2026 update: 3.8% underlying sales growth driven by 2.9% volume growth, plus major Foods combination with McCormick.
JoshuaApril 30, 2026